Teva Pharma, Teva Pharma, Tarcic Nora, Haviv Asi, Blaugrund Eran and Kaye Joel File WIPO Patent Appl...
Teva Pharma, Teva Pharma, Tarcic Nora, Haviv Asi, Blaugrund Eran and Kaye Joel File WIPO Patent Application for Use of Laquinimod for Treating Crohn's Disease Patients Who Failed First-Line Anti-TNFalpha Therapy
About this item
Full title
Teva Pharma, Teva Pharma, Tarcic Nora, Haviv Asi, Blaugrund Eran and Kaye Joel File WIPO Patent Application for Use of Laquinimod for Treating Crohn's Disease Patients Who Failed First-Line Anti-TNFalpha Therapy
Publisher
New Delhi: Pedia Content Solutions Pvt. Ltd
Journal title
Global IP News. Pharmaceutical Patent News, 2013
Language
English
Formats
Publication information
Publisher
New Delhi: Pedia Content Solutions Pvt. Ltd
More information
Alternative Titles
Full title
Teva Pharma, Teva Pharma, Tarcic Nora, Haviv Asi, Blaugrund Eran and Kaye Joel File WIPO Patent Application for Use of Laquinimod for Treating Crohn's Disease Patients Who Failed First-Line Anti-TNFalpha Therapy
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_1493568956
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1493568956
How to access this item
Log in as a Library member
